The Department of Justice (“DOJ”) is no stranger to prosecuting cases with a nexus to telehealth, especially those that involve fraud schemes billing for durable medical equipment, like braces and orthotics, or laboratory testing, such as genetic testing or COVID-19 related conditions. However, the DOJ had never prosecuted a case involving the distribution of controlled substances via telehealth….
By: Verrill
By: Verrill
